Page last updated: 2024-09-04

resiquimod and Lymphoma

resiquimod has been researched along with Lymphoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheadle, EJ; Dovedi, SJ; Fagnano, E; Honeychurch, J; Illidge, TM; Klein, C; Lipowska-Bhalla, G1
Adlard, AL; Dovedi, SJ; Honeychurch, J; Illidge, TM; Melis, MH; Stratford, IJ; Wilkinson, RW1
Greaves, P; Gribben, JG1

Other Studies

3 other study(ies) available for resiquimod and Lymphoma

ArticleYear
A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells.
    Leukemia, 2017, Volume: 31, Issue:7

    Topics: Animals; Antibodies, Monoclonal, Humanized; Antibody-Dependent Cell Cytotoxicity; Antineoplastic Agents; CD4-Positive T-Lymphocytes; Disease Models, Animal; Humans; Imidazoles; Killer Cells, Natural; Lymphocyte Activation; Lymphoma; Mice; Mice, Inbred C57BL; Rituximab; Toll-Like Receptor 7

2017
Systemic delivery of a TLR7 agonist in combination with radiation primes durable antitumor immune responses in mouse models of lymphoma.
    Blood, 2013, Jan-10, Volume: 121, Issue:2

    Topics: Animals; Antineoplastic Agents; Combined Modality Therapy; Disease Models, Animal; Imidazoles; Lymphocyte Activation; Lymphoma; Membrane Glycoproteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; T-Lymphocytes, Cytotoxic; Toll-Like Receptor 7

2013
A shot in the arm for radiotherapy.
    Blood, 2013, Jan-10, Volume: 121, Issue:2

    Topics: Animals; Antineoplastic Agents; Imidazoles; Lymphoma; Membrane Glycoproteins; Toll-Like Receptor 7

2013